Nathaniel E. David
2019
In 2019, Nathaniel E. David earned a total compensation of $1.6M as President at Unity Biotechnology, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,663 |
|---|---|
| Option Awards | $780,473 |
| Salary | $450,000 |
| Stock Awards | $189,675 |
| Other | $11,200 |
| Total | $1,611,011 |
David received $780.5K in option awards, accounting for 48% of the total pay in 2019.
David also received $179.7K in non-equity incentive plan, $450K in salary, $189.7K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Nathaniel E. David's compensation ranked 6,982nd out of 13,971 executives tracked by ExecPay. In other words, David earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,982 out of 13,971 | 50th |
Division Manufacturing | 2,671 out of 5,701 | 53rd |
Major group Chemicals And Allied Products | 978 out of 2,200 | 56th |
Industry group Drugs | 827 out of 1,886 | 56th |
Industry Pharmaceutical Preparations | 608 out of 1,398 | 57th |
Source: SEC filing on April 24, 2020.
David's colleagues
We found three more compensation records of executives who worked with Nathaniel E. David at Unity Biotechnology in 2019.